Breaking News Instant updates and real-time market news.

OPTN

Optinose

$3.92 /

-0.085 (-2.12%)

07:06
03/03/21
03/03
07:06
03/03/21
07:06

Optinose expects topline results from OPN-019 study in 2Q21

In June 2020, the Company announced the initiation of development of a new product candidate, OPN-019, which combines its proprietary intranasal Exhalation Delivery System with an antiseptic. Because components of the drug-device combination product candidate, including both the active drug and delivery device, are currently commercially available in the U.S., the Company anticipates a potential streamlined and accelerated development. Subsequent to a pre-Investigational New Drug submission the Company is engaged with FDA regarding an IND and clinical development pathway. The Company has performed in vitro testing against SARS-CoV-2 with a candidate formulation in which a 4-log reduction in virus count was produced. In addition, the Company performed tests against other pathogens. For most pathogens tested, 3-log to 6-log reductions in virus count were observed. In April 2021, the Company expects to initiate a randomized, proof of concept study in subjects who have tested positive for SARS-CoV-2 infection, are recently infected, and who have mild or no symptoms. This pilot study being conducted in Mexico will evaluate both the magnitude and duration of viral load reduction after a single dose of OPN-019. The Company expects top-line results from this study in second quarter 2021. The Company is focused on supporting the initial stages of development within our current operating expense guidance and intend to seek grants, partnerships, and/or other sources of capital to fund future development.

  • 03

    Mar

  • 03

    Mar

  • 14

    Aug

OPTN Optinose
$3.92 /

-0.085 (-2.12%)

06/30/20 Cantor Fitzgerald
OptiNose anti-COVID-19 candidate could provide 'significant upside, says Cantor

TODAY'S FREE FLY STORIES

Recommendations
Canopy Rivers price target lowered to C$2.75 from C$3.25 at CIBC » 11:50
05/11/21
05/11
11:50
05/11/21
11:50
CNPOF

Canopy Rivers

$1.67 /

-0.018 (-1.07%)

CIBC analyst John Zamparo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNPOF Canopy Rivers
$1.67 /

-0.018 (-1.07%)

CNPOF Canopy Rivers
$1.67 /

-0.018 (-1.07%)

04/05/21 CIBC
Canopy Rivers price target lowered to C$3.25 from C$4 at CIBC
02/11/21 CIBC
Canopy Rivers price target raised to C$4 from C$1.60 at CIBC
09/18/20 CIBC
Canopy Rivers price target lowered to C$1.50 from C$2 at CIBC
08/17/20 CIBC
Canopy Rivers price target lowered to C$2 from C$4.25 at CIBC
CNPOF Canopy Rivers
$1.67 /

-0.018 (-1.07%)

Earnings
Ubisoft sees Q1 net bookings roughly EUR320M » 11:50
05/11/21
05/11
11:50
05/11/21
11:50
UBSFY

Ubisoft

$15.20 /

-0.02 (-0.13%)

Yves Guillemot added,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

05/07/21 Credit Suisse
Ubisoft price target lowered to EUR 77 from EUR 85 at Credit Suisse
05/06/21 Citi
Citi opens 'Positive Catalyst Watch' on Ubisoft, sees almost 50% upside
03/03/21 Berenberg
Ubisoft price target lowered to EUR 83 from EUR 93 at Berenberg
03/03/21 Citi
Ubisoft upgraded to Buy from Neutral at Citi
UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

Conference/Events
Catalyst Biosciences participates in a conference call with Truist » 11:50
05/11/21
05/11
11:50
05/11/21
11:50
CBIO

Catalyst Biosciences

$4.49 /

-0.01 (-0.22%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CBIO Catalyst Biosciences
$4.49 /

-0.01 (-0.22%)

CBIO Catalyst Biosciences
$4.49 /

-0.01 (-0.22%)

04/29/21 Raymond James
Catalyst Biosciences assumed with an Outperform at Raymond James
04/28/21 Piper Sandler
Catalyst Biosciences should be bought 'right here,' says Piper Sandler
03/04/21 Piper Sandler
Catalyst Biosciences' momentum to build throughout 2021, says Piper Sandler
02/10/21
Fly Intel: Top five analyst initiations
CBIO Catalyst Biosciences
$4.49 /

-0.01 (-0.22%)

  • 27
    Jan
  • 18
    Jun
Earnings
Ubisoft sees FY22 net bookings growth in single digits » 11:50
05/11/21
05/11
11:50
05/11/21
11:50
UBSFY

Ubisoft

$15.20 /

-0.02 (-0.13%)

Sees FY22 non-IFRS…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

05/07/21 Credit Suisse
Ubisoft price target lowered to EUR 77 from EUR 85 at Credit Suisse
05/06/21 Citi
Citi opens 'Positive Catalyst Watch' on Ubisoft, sees almost 50% upside
03/03/21 Berenberg
Ubisoft price target lowered to EUR 83 from EUR 93 at Berenberg
03/03/21 Citi
Ubisoft upgraded to Buy from Neutral at Citi
UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

Earnings
Ubisoft reports Q4 net bookings EUR484.9M, up 16.2% » 11:49
05/11/21
05/11
11:49
05/11/21
11:49
UBSFY

Ubisoft

$15.20 /

-0.02 (-0.13%)

Frederick Duguet, Chief…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

05/07/21 Credit Suisse
Ubisoft price target lowered to EUR 77 from EUR 85 at Credit Suisse
05/06/21 Citi
Citi opens 'Positive Catalyst Watch' on Ubisoft, sees almost 50% upside
03/03/21 Berenberg
Ubisoft price target lowered to EUR 83 from EUR 93 at Berenberg
03/03/21 Citi
Ubisoft upgraded to Buy from Neutral at Citi
UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

Recommendations
Nuvei price target raised to C$110 from C$105 at CIBC » 11:49
05/11/21
05/11
11:49
05/11/21
11:49
NUVCF

Nuvei

$67.61 /

+0.36632 (+0.54%)

CIBC analyst Todd…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NUVCF Nuvei
$67.61 /

+0.36632 (+0.54%)

NUVCF Nuvei
$67.61 /

+0.36632 (+0.54%)

11:02 Today National Bank
Nuvei price target raised to C$120 from C$100 at National Bank
10:54 Today Scotiabank
Nuvei price target raised to C$106 from C$101 at Scotiabank
05/04/21 Scotiabank
Nuvei price target raised to C$101 from C$97 at Scotiabank
03/11/21 CIBC
Nuvei price target raised to C$105 from C$90 at CIBC
NUVCF Nuvei
$67.61 /

+0.36632 (+0.54%)

Recommendations
KP Tissue price target lowered to C$11 from C$12 at CIBC » 11:48
05/11/21
05/11
11:48
05/11/21
11:48
KPTSF

KP Tissue

$8.58 /

+0.36 (+4.38%)

CIBC analyst Hamir Patel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KPTSF KP Tissue
$8.58 /

+0.36 (+4.38%)

KPTSF KP Tissue
$8.58 /

+0.36 (+4.38%)

11:09 Today Desjardins
KP Tissue price target lowered to C$11.50 from C$12.50 at Desjardins
05/10/21 RBC Capital
KP Tissue price target lowered to C$10 from C$12 at RBC Capital
05/10/21 National Bank
KP Tissue price target raised to C$11 from C$10.50 at National Bank
05/10/21 Scotiabank
KP Tissue price target lowered to C$12.50 from C$13 at Scotiabank
KPTSF KP Tissue
$8.58 /

+0.36 (+4.38%)

Earnings
Ubisoft reports FY21 net bookings EUR2.24B, up 46.1% y/y » 11:48
05/11/21
05/11
11:48
05/11/21
11:48
UBSFY

Ubisoft

$15.20 /

-0.02 (-0.13%)

Reports FY21 non-IFRS…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

05/07/21 Credit Suisse
Ubisoft price target lowered to EUR 77 from EUR 85 at Credit Suisse
05/06/21 Citi
Citi opens 'Positive Catalyst Watch' on Ubisoft, sees almost 50% upside
03/03/21 Berenberg
Ubisoft price target lowered to EUR 83 from EUR 93 at Berenberg
03/03/21 Citi
Ubisoft upgraded to Buy from Neutral at Citi
UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

UBSFY Ubisoft
$15.20 /

-0.02 (-0.13%)

Recommendations
Piper says 'hard to draw meaningful conclusions' from 'messy' Tesla China data » 11:47
05/11/21
05/11
11:47
05/11/21
11:47
TSLA

Tesla

$613.93 /

-15.17 (-2.41%)

Following the overnight…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$613.93 /

-15.17 (-2.41%)

TSLA Tesla
$613.93 /

-15.17 (-2.41%)

11:37 Today Wedbush
Tesla April China deliveries see some softness, China tensions key, says Wedbush
05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
05/03/21 Mizuho
NIO price target raised to $65 from $60 at Mizuho
04/27/21 Jefferies
Tesla's 'mixed quarter' gave 'fodder for bulls and bears,' says Jefferies
TSLA Tesla
$613.93 /

-15.17 (-2.41%)

TSLA Tesla
$613.93 /

-15.17 (-2.41%)

TSLA Tesla
$613.93 /

-15.17 (-2.41%)

TSLA Tesla
$613.93 /

-15.17 (-2.41%)

Recommendations
Interfor price target raised to C$56 from C$50 at CIBC » 11:46
05/11/21
05/11
11:46
05/11/21
11:46
IFSPF

Interfor

/

+

CIBC analyst Hamir Patel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IFSPF Interfor
/

+

11:46 Today CIBC
Interfor price target raised to C$56 from C$50 at CIBC
05/10/21 BMO Capital
Interfor price target raised to C$41 from C$31 at BMO Capital
05/10/21 RBC Capital
Interfor price target raised to C$47 from C$37 at RBC Capital
05/10/21 TD Securities
Interfor price target raised to C$47 from C$44 at TD Securities
Recommendations
Interfor price target raised to C$56 from C$50 at CIBC » 11:46
05/11/21
05/11
11:46
05/11/21
11:46
IFSPF

Interfor

$30.62 /

+0.37122 (+1.23%)

CIBC analyst Hamir Patel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IFSPF Interfor
$30.62 /

+0.37122 (+1.23%)

05/10/21 BMO Capital
Interfor price target raised to C$41 from C$31 at BMO Capital
05/10/21 RBC Capital
Interfor price target raised to C$47 from C$37 at RBC Capital
05/10/21 TD Securities
Interfor price target raised to C$47 from C$44 at TD Securities
04/28/21 Scotiabank
Interfor price target raised to C$46 from C$40 at Scotiabank
Recommendations
Cervus Equipment price target raised to C$18.50 from C$16.50 at CIBC » 11:46
05/11/21
05/11
11:46
05/11/21
11:46
CSQPF

Cervus Equipment

$14.21 /

+0.1044 (+0.74%)

CIBC analyst Jacob Bout…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSQPF Cervus Equipment
$14.21 /

+0.1044 (+0.74%)

05/10/21 TD Securities
Cervus Equipment price target raised to C$21 from C$19.50 at TD Securities
03/15/21 CIBC
Cervus Equipment price target raised to C$16.50 from C$14 at CIBC
03/12/21 Raymond James
Cervus Equipment price target raised to C$19.50 from C$16 at Raymond James
03/04/21 TD Securities
Cervus Equipment upgraded to Buy from Hold at TD Securities
Recommendations
Canopy Growth price target lowered to C$38 from C$55 at CIBC » 11:45
05/11/21
05/11
11:45
05/11/21
11:45
CGC

Canopy Growth

$23.94 /

-0.23 (-0.95%)

CIBC analyst John Zamparo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGC Canopy Growth
$23.94 /

-0.23 (-0.95%)

CGC Canopy Growth
$23.94 /

-0.23 (-0.95%)

04/28/21 BofA
Tilray reinstated with a Buy at BofA
04/28/21 BofA
Canopy Growth resumed with a Buy at BofA
04/12/21 Wolfe Research
Constellation Brands initiated with an Outperform at Wolfe Research
04/09/21 Stifel
Supreme Cannabis downgraded to Sell from Buy at Stifel
CGC Canopy Growth
$23.94 /

-0.23 (-0.95%)

CGC Canopy Growth
$23.94 /

-0.23 (-0.95%)

CGC Canopy Growth
$23.94 /

-0.23 (-0.95%)

CGC Canopy Growth
$23.94 /

-0.23 (-0.95%)

Conference/Events
Jefferies healthcare services analyst to hold analyst/industry conference call » 11:45
05/11/21
05/11
11:45
05/11/21
11:45

Healthcare Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Options
Fastly Inc call volume above normal and directionally bullish » 11:45
05/11/21
05/11
11:45
05/11/21
11:45
FSLY

Fastly

$44.87 /

+2.62 (+6.20%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSLY Fastly
$44.87 /

+2.62 (+6.20%)

FSLY Fastly
$44.87 /

+2.62 (+6.20%)

09:12 Today DA Davidson
Fastly price target lowered to $60 from $105 at DA Davidson
05/06/21 Craig-Hallum
Fastly price target lowered to $55 from $80 at Craig-Hallum
05/06/21 Oppenheimer
Fastly price target lowered to $85 from $110 at Oppenheimer
05/06/21 Piper Sandler
Fastly price target lowered to $45 from $65 at Piper Sandler
FSLY Fastly
$44.87 /

+2.62 (+6.20%)

  • 21
    May
FSLY Fastly
$44.87 /

+2.62 (+6.20%)

FSLY Fastly
$44.87 /

+2.62 (+6.20%)

FSLY Fastly
$44.87 /

+2.62 (+6.20%)

Hot Stocks
Marriott's Edition announces re-opening for both New York City properties » 11:42
05/11/21
05/11
11:42
05/11/21
11:42
MAR

Marriott

$141.00 /

+0.34 (+0.24%)

EDITION, one of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAR Marriott
$141.00 /

+0.34 (+0.24%)

MAR Marriott
$141.00 /

+0.34 (+0.24%)

05/10/21 Stifel
Marriott price target raised to $140 from $120 at Stifel
02/24/21 Stifel
American Airlines price target raised to $20 from $14 at Stifel
02/22/21 Wells Fargo
Marriott price target raised to $154 from $147 at Wells Fargo
02/22/21 Wells Fargo
Wells Fargo strategist upgrades Consumer Services sector to Overweight
MAR Marriott
$141.00 /

+0.34 (+0.24%)

MAR Marriott
$141.00 /

+0.34 (+0.24%)

MAR Marriott
$141.00 /

+0.34 (+0.24%)

MAR Marriott
$141.00 /

+0.34 (+0.24%)

Conference/Events
Jefferies software/Internet analyst to hold analyst/industry conference call » 11:41
05/11/21
05/11
11:41
05/11/21
11:41

Software & Internet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Veeco participates in a conference call hosted by Northland » 11:40
05/11/21
05/11
11:40
05/11/21
11:40
VECO

Veeco

$21.65 /

-0.23 (-1.05%)

Northland holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VECO Veeco
$21.65 /

-0.23 (-1.05%)

VECO Veeco
$21.65 /

-0.23 (-1.05%)

05/05/21 Oppenheimer
Veeco price target raised to $29 from $25 at Oppenheimer
05/04/21 Stifel
Intel spending plans show new CEO 'gets it,' says Stifel
03/10/21 Barclays
Veeco price target raised to $26 from $24 at Barclays
02/12/21 Barclays
Veeco price target raised to $24 from $22 at Barclays
VECO Veeco
$21.65 /

-0.23 (-1.05%)

VECO Veeco
$21.65 /

-0.23 (-1.05%)

Recommendations
Ensign Energy price target lowered to C$1.40 from C$1.75 at BMO Capital » 11:40
05/11/21
05/11
11:40
05/11/21
11:40
ESVIF

Ensign Energy

/

+

BMO Capital analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESVIF Ensign Energy
/

+

10:49 Today TD Securities
Ensign Energy price target lowered to C$1.40 from C$1.50 at TD Securities
03/09/21 Stifel
Ensign Energy price target raised to C$1.40 from C$1.25 at Stifel
03/08/21 RBC Capital
Ensign Energy price target raised to C$1.75 from C$1.50 at RBC Capital
03/08/21 BMO Capital
Ensign Energy price target raised to C$1.50 from C$1.25 at BMO Capital
Conference/Events
Twilio management to meet virtually with Mizuho » 11:39
05/11/21
05/11
11:39
05/11/21
11:39
TWLO

Twilio

$302.72 /

+8.11 (+2.75%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWLO Twilio
$302.72 /

+8.11 (+2.75%)

TWLO Twilio
$302.72 /

+8.11 (+2.75%)

05/06/21 Mizuho
Twilio price target lowered to $400 from $475 at Mizuho
04/22/21 Wolfe Research
Twilio assumed with an Outperform at Wolfe Research
04/20/21 BofA
Twilio reinstated with a Buy at BofA
04/20/21 BofA
Twilio initiated with a Buy at BofA
TWLO Twilio
$302.72 /

+8.11 (+2.75%)

  • 19
    Feb
  • 07
    Aug
TWLO Twilio
$302.72 /

+8.11 (+2.75%)

TWLO Twilio
$302.72 /

+8.11 (+2.75%)

TWLO Twilio
$302.72 /

+8.11 (+2.75%)

Recommendations
Power Corporation price target raised to C$39 from C$38 at BMO Capital » 11:39
05/11/21
05/11
11:39
05/11/21
11:39
PWCDF

Power Corporation

$30.49 /

+0.271 (+0.90%)

BMO Capital analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PWCDF Power Corporation
$30.49 /

+0.271 (+0.90%)

10:55 Today Scotiabank
Power Corporation price target raised to C$44 from C$40 at Scotiabank
05/05/21 Desjardins
Power Corporation price target raised to C$41 from C$37 at Desjardins
05/04/21 CIBC
Power Corporation price target raised to C$41 from C$40 at CIBC
05/04/21 BMO Capital
Power Corporation price target raised to C$38 from C$35 at BMO Capital
Recommendations
Chartwell Retirement price target raised to C$13.25 from C$12 at BMO Capital » 11:38
05/11/21
05/11
11:38
05/11/21
11:38
CWSRF

Chartwell Retirement

$10.78 /

+0.38513 (+3.71%)

BMO Capital analyst Troy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CWSRF Chartwell Retirement
$10.78 /

+0.38513 (+3.71%)

10:59 Today National Bank
Chartwell price target raised to C$14.50 from C$13.50 at National Bank
05/10/21 TD Securities
Chartwell Retirement price target raised to C$14 from C$13 at TD Securities
11/10/20 RBC Capital
Chartwell Retirement price target raised to C$12.50 from C$11.50 at RBC Capital
11/09/20 National Bank
Chartwell Retirement price target raised to C$13.50 from C$12 at National Bank
Conference/Events
Resideo management to meet virtually with Oppenheimer » 11:38
05/11/21
05/11
11:38
05/11/21
11:38
REZI

Resideo

$28.03 /

-0.55 (-1.92%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REZI Resideo
$28.03 /

-0.55 (-1.92%)

REZI Resideo
$28.03 /

-0.55 (-1.92%)

03/17/21 Morgan Stanley
Resideo initiated with an Equal Weight at Morgan Stanley
03/11/21
Fly Intel: Top five analyst downgrades
03/11/21 Roth Capital
Resideo downgraded to Neutral from Buy at Roth Capital
03/03/21 William Blair
William Blair starts 'overlooked' Resideo with Market Perform rating
REZI Resideo
$28.03 /

-0.55 (-1.92%)

  • 18
    Nov
REZI Resideo
$28.03 /

-0.55 (-1.92%)

Recommendations
Tesla April China deliveries see some softness, China tensions key, says Wedbush » 11:37
05/11/21
05/11
11:37
05/11/21
11:37
TSLA

Tesla

$614.97 /

-14.13 (-2.25%)

, NIO

NIO

$34.58 /

+0.28 (+0.82%)

, XPEV

XPeng

$24.61 /

-0.85 (-3.34%)

, LI

Li Auto

$16.84 /

-0.175 (-1.03%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$614.97 /

-14.13 (-2.25%)

NIO NIO
$34.58 /

+0.28 (+0.82%)

XPEV XPeng
$24.61 /

-0.85 (-3.34%)

LI Li Auto
$16.84 /

-0.175 (-1.03%)

TSLA Tesla
$614.97 /

-14.13 (-2.25%)

05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
05/03/21 Mizuho
NIO price target raised to $65 from $60 at Mizuho
04/27/21 Jefferies
Tesla's 'mixed quarter' gave 'fodder for bulls and bears,' says Jefferies
04/27/21 Wedbush
Tesla delivers 'strong' results, EV demand looks robust, says Wedbush
NIO NIO
$34.58 /

+0.28 (+0.82%)

05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
05/03/21 Morgan Stanley
NIO on track for Q2 target after April deliveries, says Morgan Stanley
05/03/21 Mizuho
NIO price target raised to $65 from $60 at Mizuho
04/23/21
Fly Intel: Top five analyst initiations
XPEV XPeng
$24.61 /

-0.85 (-3.34%)

05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
04/13/21 Morgan Stanley
Morgan Stanley cuts Ehang to Equal Weight on regulatory, competitive uncertainty
03/22/21 Deutsche Bank
XPeng confident about near-term demand trajectory, says Deutsche Bank
03/10/21 Citi
Xpeng price target lowered to $50 from $57.71 at Citi
LI Li Auto
$16.84 /

-0.175 (-1.03%)

05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
03/11/21
Fly Intel: Top five analyst initiations
03/11/21 Needham
Li Auto initiated with a Buy at Needham
03/11/21 Needham
Li Auto initiated with a Buy at Needham
TSLA Tesla
$614.97 /

-14.13 (-2.25%)

NIO NIO
$34.58 /

+0.28 (+0.82%)

XPEV XPeng
$24.61 /

-0.85 (-3.34%)

LI Li Auto
$16.84 /

-0.175 (-1.03%)

  • 14
    Dec
  • 09
    Dec
  • 04
    Dec
  • 31
    Aug
  • 27
    Aug
  • 30
    Jul
  • 11
    Jun
TSLA Tesla
$614.97 /

-14.13 (-2.25%)

NIO NIO
$34.58 /

+0.28 (+0.82%)

XPEV XPeng
$24.61 /

-0.85 (-3.34%)

LI Li Auto
$16.84 /

-0.175 (-1.03%)

TSLA Tesla
$614.97 /

-14.13 (-2.25%)

NIO NIO
$34.58 /

+0.28 (+0.82%)

XPEV XPeng
$24.61 /

-0.85 (-3.34%)

LI Li Auto
$16.84 /

-0.175 (-1.03%)

TSLA Tesla
$614.97 /

-14.13 (-2.25%)

NIO NIO
$34.58 /

+0.28 (+0.82%)

XPEV XPeng
$24.61 /

-0.85 (-3.34%)

LI Li Auto
$16.84 /

-0.175 (-1.03%)

Conference/Events
Douglas Dynamics management to meet virtually with Craig Hallum » 11:37
05/11/21
05/11
11:37
05/11/21
11:37
PLOW

Douglas Dynamics

$43.34 /

-1.74 (-3.86%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLOW Douglas Dynamics
$43.34 /

-1.74 (-3.86%)

02/24/21 Craig-Hallum
Douglas Dynamics price target raised to $45 from $38 at Craig-Hallum
02/03/21 Baird
Douglas Dynamics upgraded to Outperform from Neutral at Baird
PLOW Douglas Dynamics
$43.34 /

-1.74 (-3.86%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.